Suppr超能文献

眼眶血管畸形的临床评估与病变特异性管理

Clinical Assessment and Lesion-Specific Management of Orbital Vascular Malformations.

作者信息

Rootman Daniel B, Diniz Stefania B, Cohen Liza M

机构信息

Division of Orbital and Ophthalmic Plastic Surgery, Doheny and Stein Eye Institutes, University of California, Los Angeles, United States.

出版信息

J Neurol Surg B Skull Base. 2021 Feb;82(1):116-128. doi: 10.1055/s-0040-1722702. Epub 2021 Mar 23.

Abstract

The systematic classification of vascular disease as proposed and refined by the International Society for the Study of Vascular Anomalies (ISSVA) divides vascular pathology first into tumors and malformations. Malformations are described as simple and complex, where simple malformations contain a single vascular system and complex malformations comprised of multiple vascular systems. Arteriovenous malformations are considered in terms of inflow characteristics which are primarily responsible for the key management challenges. Management utilizing endovascular embolization and/or surgical resection is often employed; however, recurrence can occur, particularly in diffuse cases. There may be an increasing role for systemic antiangiogenic therapy in such cases. Lymphaticovenous malformations are divided into the principle components on the lymphatic and venous sides for clarity of discussion. Lymphatic malformations are described morphologically as macrocystic and microcystic, and physiologically in terms of the processes responsible for growth. In both cases, surgical options are challenging and local therapeutics intended to close large luminal spaces in the case of macrocystic and to slow biological signaling for growth in microcystic. Venous malformations are described physiologically in terms of flow and distensibility, as volume plays a critical role in the limited space of the orbital cavity. Combined embolic-surgical approaches can be effective for management. More complicated, combined lesions can be managed by dividing the lesion into principal components and treating each appropriately.

摘要

国际血管异常研究学会(ISSVA)提出并完善的血管疾病系统分类法,首先将血管病理学分为肿瘤和畸形。畸形被描述为简单型和复杂型,其中简单畸形包含单一血管系统,复杂畸形由多个血管系统组成。动静脉畸形根据流入特征来考虑,这些特征是关键管理挑战的主要原因。通常采用血管内栓塞和/或手术切除进行治疗;然而,复发可能会发生,尤其是在弥漫性病例中。在这种情况下,全身抗血管生成治疗的作用可能会越来越大。为了便于讨论,淋巴管静脉畸形分为淋巴和静脉两方面的主要成分。淋巴畸形在形态上被描述为大囊型和微囊型,在生理上根据生长相关过程来描述。在这两种情况下,手术选择都具有挑战性,对于大囊型,局部治疗旨在封闭大的腔隙,对于微囊型,旨在减缓生长的生物信号传导。静脉畸形在生理上根据血流和扩张性来描述,因为体积在眼眶有限的空间中起着关键作用。联合栓塞 - 手术方法对治疗可能有效。更复杂的联合病变可以通过将病变分为主要成分并分别进行适当治疗来处理。

相似文献

1
Clinical Assessment and Lesion-Specific Management of Orbital Vascular Malformations.
J Neurol Surg B Skull Base. 2021 Feb;82(1):116-128. doi: 10.1055/s-0040-1722702. Epub 2021 Mar 23.
2
Utilizing immediate preoperative n-BCA in the resection of head and neck venous and lymphatic malformations.
Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110388. doi: 10.1016/j.ijporl.2020.110388. Epub 2020 Sep 17.
6
Vascular malformations of the orbit (lymphatic, venous, arteriovenous): Diagnosis, management and results.
J Craniomaxillofac Surg. 2019 May;47(5):726-740. doi: 10.1016/j.jcms.2018.09.009. Epub 2018 Sep 20.
8
Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
Ophthalmic Plast Reconstr Surg. 2012 Mar-Apr;28(2):119-25. doi: 10.1097/IOP.0b013e318242ab0f.
9
Management of cervicofacial lymphatic malformations requires a multidisciplinary approach.
J Pediatr Surg. 2021 May;56(5):1062-1067. doi: 10.1016/j.jpedsurg.2020.09.017. Epub 2020 Sep 30.
10
Pelvic vascular malformations.
Semin Intervent Radiol. 2013 Dec;30(4):364-71. doi: 10.1055/s-0033-1359730.

引用本文的文献

1
Ultrasound-guided sclerotherapy of pingyangmycin for periorbital lymphatic malformations.
BMC Ophthalmol. 2025 May 30;25(1):319. doi: 10.1186/s12886-025-04154-0.
2
Classification, diagnosis, and management of orbital venous-lymphatic malformations: Current state-of-the-art.
Taiwan J Ophthalmol. 2025 Mar 10;15(1):4-13. doi: 10.4103/tjo.TJO-D-24-00151. eCollection 2025 Jan-Mar.
3
Post-treatment Recovery in Orbital Arteriovenous Fistulas: A Systematic Review.
Cureus. 2024 Dec 7;16(12):e75282. doi: 10.7759/cureus.75282. eCollection 2024 Dec.
4
Never Regret Trying Image-Guided Sclerotherapy in Orbital Low-Flow Malformation.
Indian J Radiol Imaging. 2024 Jul 16;35(1):199-202. doi: 10.1055/s-0044-1788552. eCollection 2025 Jan.
5
A Simple Orbital Lymphatic Malformation Clinically Mimics Primary Conjunctival Cyst.
Case Rep Ophthalmol. 2024 Jul 25;15(1):577-584. doi: 10.1159/000540126. eCollection 2024 Jan-Dec.
6
Image-Guided Percutaneous Sclerotherapy for Orbital Low-Flow Malformation: Our Experience.
Indian J Radiol Imaging. 2024 Feb 28;34(3):539-544. doi: 10.1055/s-0044-1779689. eCollection 2024 Jul.

本文引用的文献

2
Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation.
Nat Commun. 2020 Jun 8;11(1):2869. doi: 10.1038/s41467-020-16496-y.
3
Diagnosis and Management of Acute Thrombosis in Venous Dominant Orbital Venolymphatic Malformations.
Ophthalmic Plast Reconstr Surg. 2020 Jul/Aug;36(4):359-364. doi: 10.1097/IOP.0000000000001553.
4
Extracranial arteriovenous malformations: from bedside to bench.
Mutagenesis. 2019 Dec 19;34(4):299-306. doi: 10.1093/mutage/gez028.
5
Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions: Systematic review and meta-analysis.
Surv Ophthalmol. 2020 Jan-Feb;65(1):41-47. doi: 10.1016/j.survophthal.2019.08.003. Epub 2019 Aug 16.
6
Embolization of brain arteriovenous malformations with intent to cure: a systematic review.
J Neurosurg. 2020 Feb 1;132(2):388-399. doi: 10.3171/2018.10.JNS181791. Epub 2019 Feb 1.
7
Multimodality Management of Complex Periorbital Venolymphatic Malformations.
Ophthalmic Plast Reconstr Surg. 2019 Jul/Aug;35(4):387-398. doi: 10.1097/IOP.0000000000001294.
8
Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.
Cardiovasc Intervent Radiol. 2019 Mar;42(3):433-440. doi: 10.1007/s00270-018-2128-4. Epub 2018 Nov 28.
9
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.
J Clin Invest. 2018 Apr 2;128(4):1496-1508. doi: 10.1172/JCI98589. Epub 2018 Mar 12.
10
Sirolimus-induced regression of a large orbital lymphangioma.
Orbit. 2019 Feb;38(1):79-80. doi: 10.1080/01676830.2018.1436569. Epub 2018 Feb 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验